NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05375110

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Hangzhou NOYA MedTech Co. Ltm. (from the registry)
Registry
  • NCT NCT05375110
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05375110. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-10 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)
Condition
Heart Failure
Intervention (Device)
NoYA™ Radiofrequency Interatrial Shunt System
Lead sponsor
Hangzhou NOYA MedTech Co. Ltm. (class: industry)

Record details

Record id
cardio:ct-nct05375110
Content hash
ed829a0dd19877a5a0ca6cf5b4ad47044dff4a323bbbd70c765676f74a54c365